Less is More? First Impressions From COSMIC-313
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Investigation"
DOI: 10.1080/07357907.2022.2136681
Abstract: Abstract The COSMIC-313 phase 3 randomized controlled trial tested the triplet combination of cabozantinib with nivolumab and ipilimumab in comparison with nivolumab plus ipilimumab control as fist-line systemic therapy in metastatic clear cell renal cell… read more here.
Keywords: oncology; cell; less first; first impressions ... See more keywords